Rocuronium Bromide Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Rocuronium Bromide Injection (injection) from Mylan Institutional, A Viatris Company with status Current. The shortage was first posted on Feb 15, 2023.
Shortage details
- Status
- Current
- Company
- Mylan Institutional, A Viatris Company
- Package NDC
- 67457-228-05
- Dosage Form
- Injection
- Presentation
- Rocuronium Bromide, Injection, 10 mg/1 mL (NDC 67457-228-05)
- Initial Posting
- Feb 15, 2023